Cross-seeding effects of amyloid β-protein and α-synuclein

Journal of Neurochemistry

Volumn 122, Issue 5, 2012, Pages 883-890

  Ono, Kenjiro ^a   Takahashi, Ryoichi ^a   Ikeda, Tokuhei ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

synuclein; aggregation; Alzheimer's disease; amyloid protein; Lewy body diseases; seed

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; OLIGOMER; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL PHENOMENA; CONTROLLED STUDY; CROSS LINKING; CROSS SEEDING; DIFFUSE LEWY BODY DISEASE; ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; ULTRASOUND;

ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; ANIMALS; CHROMATOGRAPHY, GEL; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PROTEIN BINDING; THIAZOLES;

EID: 84865336939     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07847.x     Document Type: Article

References (36)

1. Agnati L. F., Guidolin D., Baluska F., Leo G., Barlow P. W., Carone C., and, Genedani S., (2010) A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevance for Alzheimer's disease. Curr. Alzheimer Res. 7, 307-322.
2. Armstrong R. A., Cairns N. J., and, Lantos P. L., (1997) β-Amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci. Lett. 227, 193-196. (Pubitemid 27243976)
3. Eisele Y. S., Bolmont T., Heikenwalder M., et al. (2009) Induction of cerebral β-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl Acad. Sci. USA 106, 12926-12931.
4. El-Agnaf O. M., Salem S. A., Paleologou K. E., et al. (2003) α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 17, 1945-1947.
5. Gajdusek D. C., (1994) Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses. Mol. Neurobiol. 8, 1-13.
6. Hamilton R. L., (2000) Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol. 10, 378-384. (Pubitemid 30431290)
7. Hasegawa K., Yamaguchi I., Omata S., Gejyo F., and, Naiki H., (1999) Interaction between Aβ(1-42) and Aβ(1-40) in Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 38, 15514-15521. (Pubitemid 129503592)
8. Jarrett J. T., and, Lansbury Jr P. T., (1993) Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058. (Pubitemid 23180480)
9. Kim H. Y., Cho M. K., Kumar A., et al. (2009) Structural properties of pore-forming oligomers of α-synuclein. J. Am. Chem. Soc. 131, 17482-17489.
10. Kordower J. H., Chu Y., Hauser R. A., Freeman T. B., and, Olanow C. W., (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14, 504-506. (Pubitemid 351655212)
11. Kurata T., Kawarabayashi T., Murakami T., et al. (2007) Enhanced accumulation of phosphorylated α-synuclein in double transgenic mice expressing mutant β-amyloid precursor protein and presenilin-1. J. Neurosci. Res. 85, 2246-2252. (Pubitemid 47172156)
12. Langer F., Eisele Y. S., Fritschi S. K., Staufenbiel M., Walker L. C., and, Jucker M., (2011) Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J. Neurosci. 31, 14488-14495.
13. LeVine 3rd H., (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol., 309, 274-284.
14. Li J. Y., Englund E., Holton J. L., et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503. (Pubitemid 351655211)
15. Lippa S. M., Lippa C. F., and, Mori H., (2005) α-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of β-amyloid plaque level. Am. J. Alzheimers Dis. Other Demen. 20, 315-318. (Pubitemid 41502373)
16. Lucking C. B., and, Brice A., (2000) α-synuclein and Parkinson's disease. Cell. Mol. Life Sci. 57, 1894-1908.
17. Mandal P. K., Pettegrew J. W., Masliah E., Hamilton R. L., and, Mandal R., (2006) Interaction between Aβ peptide and α synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease. Neurochem. Res. 31, 1153-1162. (Pubitemid 44379676)
18. Masliah E., Rockenstein E., Veinbergs I., Sagara Y., Mallory M., Hashimoto M., and, Mucke L., (2001) β-amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 12245-12250. (Pubitemid 32959858)
19. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., et al. (2006) Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781-1784. (Pubitemid 44454153)
20. Ono K., and, Yamada M., (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro. J. Neurochem. 97, 105-115.
21. Ono K., and, Yamada M., (2011) Low-n oligomers as therapeutic targets of Alzheimer's disease. J. Neurochem. 117, 19-28.
22. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., and, Yamada M., (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 87, 172-181. (Pubitemid 37210651)
23. Ono K., Condron M. M., Ho L., Wang J., Zhao W., Pasinetti G. M., and, Teplow D. B., (2008) Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. J. Biol. Chem. 283, 32176-32187.
24. Ono K., Condron M. M., and, Teplow D. B., (2009) Structure-neurotoxicity relationships of amyloid β-protein oligomers. Proc. Natl Acad. Sci. USA 106, 14745-14750.
25. Ono K., Condron M. M., and, Teplow D. B., (2010) Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity. J. Biol. Chem. 285, 23186-23197.
26. Ono K., Ikeda T., Takasaki J., and, Yamada M., (2011) Familial Parkinson disease mutations influence α-synuclein assembly. Neurobiol. Dis. 43, 715-724.
27. Ono K., Mochizuki H., Ikeda T., Nihira T., Takasaki J. I., Teplow D. B., and, Yamada M,. (2012) Effect of melatonin on α-synuclein self-assembly and cytotoxicity. Neurobiol. Aging 33, 2172-2185.
28. Pletnikova O., West N., Lee M. K., Rudow G. L., Skolasky R. L., Dawson T. M., Marsh L., and, Troncoso J. C., (2005) Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases. Neurobiol. Aging 26, 1183-1192. (Pubitemid 40726011)
29. Steinerman J. R., Irizarry M., Scarmeas N., Raju S., Brandt J., Albert M., Blacker D., Hyman B., and, Stern Y., (2008) Distinct pools of β-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch. Neurol. 65, 906-912. (Pubitemid 352008473)
30. Tokuda T., Qureshi M. M., Ardah M. T., et al. (2010) Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75, 1766-1772.
31. Tsigelny I. F., Crews L., Desplats P., et al. (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 3, e3135.
32. Walsh D. M., Tseng B. P., Rydel R. E., Podlisny M. B., and, Selkoe D. J., (2000) The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831-10839.
33. Wood S. J., Wetzel R., Martin J. D., and, Hurle M. R., (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 34, 724-730.
34. Wood S. J., Wypych J., Steavenson S., Louis J. C., Citron M., and, Biere A. L., (1999) α-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274, 19509-19512.
35. Yang F., Ueda K., Chen P., Ashe K. H., and, Cole G. M., (2000) Plaque-associated α-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res. 853, 381-383. (Pubitemid 30035240)
36. Yoshimoto M., Iwai A., Kang D., Otero D. A., Xia Y., and, Saitoh T., (1995) NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl Acad. Sci. USA 92, 9141-9145.